A path-analytical approach to differentiate between direct and indirect drug effects on negative symptoms in schizophrenic patients. A re-evaluation of the North American risperidone study - Moller, H J; Muller, H; Borison, R L (Eur Arch Psychiatry Clin Neurosci, 1995)
et al.